AI Enhanced RIMS: What the Future Holds for Regulatory
Christina Johnston, Associate Director of Product Management for Regulatory at ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Christina Johnston, Associate Director of Product Management for Regulatory at ...
Pharmaceutical companies, service providers, and solution providers should focus on as technology advancements continue to transform drug safety for the future. Read the blog
LifeSphere Safety MultiVigilance (LSSMV) database system has auto-translation capabilities that can translate safety narratives from English to Chinese and vice versa using advanced machine-learning technology.
“Driving insights to action” was this year’s DIA Annual conference ...
If you’re in Regulatory Affairs, you know the IDMP-compliance-truck is ...
By Danilo Pavlovic As both a conference attendee and ArisGlobal ...
The very basis of pharmacovigilance is to detect, collect, monitor, ...
Considering switching from a paper trial master file to an ...
With declining R&D budgets, increased competition from larger CROs and ...
Learn how exciting new technological innovations are set to impact how regulatory information management teams work in 2024 and beyond.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved